Abu Bakar, Ruzilawati
(2008)
Population Pharmacokinetics Of Repaglinide In
Healthy Subjects And Genetic Polymorphisms Of
Cyp3a4 And Cyp2c8.
PhD thesis, USM.
Abstract
Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat
penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh
enzim CYP3A4 dan CYP2C8.
Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of
type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4
and CYP2C8 enzymes.
Actions (login required)
|
View Item |